← Back to Clinical Trials
Recruiting NCT05885646

Effect of Sulthiame on EEG in Childhood Epilepsy Syndromes

Trial Parameters

Condition Importance of Interictal Epileptiform Activity on Sleep EEG
Sponsor University Hospital, Angers
Study Type OBSERVATIONAL
Phase N/A
Enrollment 15
Sex ALL
Min Age 6 Years
Max Age 15 Years
Start Date 2023-10-17
Completion 2025-12-01
Interventions
Sulthiame

Brief Summary

The effect of sulthiame on EEG has been studied in epilepsy syndromes of childhood with sleep activation by comparing sleep EEG obtained at baseline and after 4 weeks of treatment. The aim of the study is to know if an effect is still identifiable after 2 weeks of treatment by performing sleep EEG recordings after 2 and 4 weeks of treatment, respectively.

Eligibility Criteria

Inclusion Criteria: * Diagnosis of epilepsy syndromes of childhood with sleep activation * Failure of at least two anti-epileptic drugs (AED) * Sleep EEG performed in the last 7 days before inclusion and showing interictal epileptiform discharges (baseline EEG) Exclusion Criteria: * Previous trial with sulthiame * More than 2 AED at inclusion * Use of corticosteroids at inclusion * Change in the anti-epileptic treatment in the 7 days before baseline EEG

Related Trials